Published Date: September 01, 2009
Researchers assess HIV vaccine acceptability among high-risk adults in Los Angeles. Findings support development of social marketing interventions to increase acceptability of "partial efficacy" vaccines, behavioral interventions to mitigate risk compensation and targeted cost subsidies.

Publication Authors:
  • Peter A. Newman, PhD
  • Sung-Jae Lee, PhD
  • Naihua Duan
  • Ellen Rudy
  • Terry T. Nakazono
  • John Boscardin
  • Lisa Kakinami
  • Steven Shoptaw
  • Allison L. Diamant, MD, MSHS
  • William E. Cunningham, MD, MPH